FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Lupin Pharmaceuticals Nystatin and Triamcinolone Acetonide Cream Recall

Nystatin and Triamcinolone Acetonide Cream USP100,000 units/g, 0

Lupin Pharmaceuticals Inc. · Baltimore, MD

Risk level
Class III
Reported by FDA
Jul 31, 2019
Recall ID
D-1518-2019
Check your lot numberHow we source this data

Summary

Lupin Pharmaceuticals recalled Nystatin and Triamcinolone Acetonide Cream starting Jul 17, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1518-2019 on Jul 31, 2019. Reason: Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for upright orientation. Status: Terminated.

Why it was recalled

Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for upright orientation.

Product description

Nystatin and Triamcinolone Acetonide Cream USP100,000 units/g, 0.1%, 15 g tube, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 INDIA, NDC 68180-545-01

Lot numbers, UPCs & expiration codes

Lot #: K800245, Exp. Dec 2019; K900036 Exp. Sep 20; K900153, Exp. 09/2020

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1518-2019
Classification
Class III
Status
Terminated
Recall initiated
Jul 17, 2019
FDA report date
Jul 31, 2019
Quantity
33,939 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Lupin Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-1518-2019, exactly as published.

Show all FDA fields
City
Baltimore
State
MD
Status
Terminated
Country
United States
Event ID
83350
Address
111 S Calvert St Fl 21ST
Code information
Lot #: K800245, Exp. Dec 2019; K900036 Exp. Sep 20; K900153, Exp. 09/2020
Postal code
21202-6174
Report date
Jul 31, 2019
Product type
Drugs
Recall number
D-1518-2019
Classification
Class III
Recalling firm
Lupin Pharmaceuticals Inc.
Product quantity
33,939 tubes
Termination date
Sep 14, 2020
Reason for recall
Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for upright orientation.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Nystatin and Triamcinolone Acetonide Cream USP100,000 units/g, 0.1%, 15 g tube, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 INDIA, NDC 68180-545-01
Distribution pattern
Nationwide within the United States
Recall initiation date
Jul 17, 2019
Initial firm notification
Letter
Center classification date
Jul 25, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1518-2019, published Jul 31, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls